A. Ohtsu

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.

K. Sugimachi, A. Ohtsu, T. Taguchi, 1998, European journal of cancer.

Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma

K. Sugimachi, T. Taguchi, Y. Sakata, 2000, British Journal of Cancer.

Synthesis and Characterization of Imidazolate-Bridged Dinuclear Complexes as Active Site Models of Cu,Zn-SOD

S. Fukuzumi, E. Itoh, S. Itoh, 2000 .

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.

K. Sugimachi, T. Taguchi, Y. Sakata, 2000, British journal of cancer.

The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody.

A. Ohtsu, S. Takahama, T. Fujii, 1996, Journal of pharmaceutical and biomedical analysis.